BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8009260)

  • 1. Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
    Fritz P; Lioté F; Kuntz D
    Semin Arthritis Rheum; 1994 Feb; 23(4):282. PubMed ID: 8009260
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
    Grauer A; Klar B; Scharla SH; Zieglar R
    Semin Arthritis Rheum; 1994 Feb; 23(4):283-4. PubMed ID: 8009261
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
    Stuckey BG; Gutteridge DH; Stewart GO; Prince RL; Ward LC; Kent GN; Prince RI; Retallack RW; Bhagat CI; Nicholson GC
    Semin Arthritis Rheum; 1994 Feb; 23(4):286. PubMed ID: 8009263
    [No Abstract]   [Full Text] [Related]  

  • 4. Response of biochemical markers of bone turnover to pamidronate infusion in Paget's disease of bone.
    Sharp CA; Worsfold M; Rowlands PR; Davie MW
    Semin Arthritis Rheum; 1994 Feb; 23(4):242-3. PubMed ID: 8009239
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of intravenous aminopropylidene bisphosphonate in patients with refractory Paget's disease.
    Cormier C; Hilliquin P; Menkès CJ
    Br J Rheumatol; 1993 Aug; 32(8):767-8. PubMed ID: 8348290
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of intravenous pamidronate therapy on Paget's disease of bone.
    Bombassei GJ; Yocono M; Raisz LG
    Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous pamidronate: evolution of an effective treatment strategy.
    Anderson DC; Richardson PC; Brown JK; Freemont AJ; Hollis S; Denton J; Buckler HM; Hargreaves S; Cantrill JA
    Semin Arthritis Rheum; 1994 Feb; 23(4):273-5. PubMed ID: 8009254
    [No Abstract]   [Full Text] [Related]  

  • 8. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.
    Thiébaud D; Jaeger P; Gobelet C; Jacquet AF; Burckhardt P
    Am J Med; 1988 Aug; 85(2):207-12. PubMed ID: 3261129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with pamidronate in the treatment of Paget's disease of bone.
    Gallacher SJ; Boyce BF; Patel U; Jenkins A; Ralston SH; Boyle IT
    Ann Rheum Dis; 1991 Dec; 50(12):930-3. PubMed ID: 1768163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
    Harinck HI; Papapoulos SE; Blanksma HJ; Moolenaar AJ; Vermeij P; Bijvoet OL
    Br Med J (Clin Res Ed); 1987 Nov; 295(6609):1301-5. PubMed ID: 3120987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
    Gutteridge DH; Retallack RW; Ward LC; Stuckey BG; Stewart GO; Prince RL; Kent GN; Bhagat CI; Price RI; Thompson RI; Nicholson GC
    Bone; 1996 Oct; 19(4):387-94. PubMed ID: 8894145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
    Heynen G; Delwaide P; Bijvoet OL; Franchimont P
    Eur J Clin Invest; 1982 Feb; 12(1):29-35. PubMed ID: 6802650
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)].
    Scharla SH; Grauer A; Ziegler R
    Klin Wochenschr; 1991 Jan; 69(1):25-30. PubMed ID: 2016845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.
    Cantrill JA; Buckler HM; Anderson DC
    Ann Rheum Dis; 1986 Dec; 45(12):1012-8. PubMed ID: 3813665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the bisphosphonate space in treatment and retreatment of Paget's disease.
    Stone MD; Patel S; Hosking DJ
    Semin Arthritis Rheum; 1994 Feb; 23(4):278. PubMed ID: 8009256
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Paget's disease of bone with single dose intravenous pamidronate.
    Watts RA; Skingle SJ; Bhambhani MM; Pountain G; Crisp AJ
    Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Paget's disease of bone with intravenous pamidronate: comparison of 2 different modes of treatment.
    Ismail AA; Fox P; Stamp TC; Dhillon V; Crisp AJ; MacGregor A
    J Rheumatol; 1997 Nov; 24(11):2266-7. PubMed ID: 9375899
    [No Abstract]   [Full Text] [Related]  

  • 18. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ; Gunasekera RD
    Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
    Stone MD; Hawthorne AB; Kerr D; Webster G; Hosking DJ
    J Bone Miner Res; 1990 Dec; 5(12):1231-5. PubMed ID: 2075835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy.
    Patel S; Coupland CA; Stone MD; Hosking DJ
    Bone; 1995 Feb; 16(2):193-7. PubMed ID: 7756047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.